Return to homepagePandemic Pact

Characterize and optimize adjuvants to test monkeypox vaccines

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 75N93019C00045-P00012-9999-2

Grant search

Key facts

  • Disease

    mpox

  • Start & end year

    2021
    2022

  • Known Financial Commitments (USD)

    $1,599,006

  • Funder

    National Institutes of Health (NIH)

  • Principal Investigator

    JAY EVANS

  • Research Location

    United States of America

  • Lead Research Institution

    University Of Montana

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

  • Mpox Research Priorities

    Vaccines research, development and implementation

  • Mpox Research Sub Priorities

    Development of equitable, accessible, safe and effective vaccines

Abstract

To identify novel classes of adjuvants, characterize and optimize them, and test them in vivo with various antigens from different pathogens.